Comparison of Cardiac Findings in Pediatric Patients with Multisystem Inflammatory Syndrome in Children Associated

Seval Ozen1, Harun Terin2, Pinar Bayraktar1

  • 1Department of Pediatric Infectious Diseases, Ankara City Hospital, Ankara, Türkiye.

Sisli Etfal Hastanesi Tip Bulteni
|August 4, 2025
PubMed

Insights

Multisystem inflammatory syndrome in children (MIS-C) can cause cardiac dysfunction and coronary artery abnormalities (CAAs). Older children with MIS-C and cardiac issues had higher inflammatory markers and lower albumin levels.

Area of Science:

  • Pediatric Cardiology
  • Infectious Diseases
  • Critical Care Medicine

Background:

  • Multisystem inflammatory syndrome in children (MIS-C) is a serious hyperinflammatory condition post-COVID-19.
  • Cardiovascular abnormalities, including cardiac dysfunction and coronary artery abnormalities (CAAs), are common in MIS-C.
  • Predicting which children develop cardiac involvement in MIS-C is crucial for management.

Purpose of the Study:

  • To investigate demographic, echocardiographic, laboratory, and outcome differences in MIS-C patients based on cardiac involvement.
  • To identify factors associated with myocardial dysfunction and CAAs in MIS-C.
  • To compare MIS-C patient characteristics across four groups defined by cardiac involvement.

Main Methods:

  • Retrospective analysis of 135 MIS-C patients diagnosed between July 2020 and August 2022.
  • Patients categorized into four groups based on myocardial dysfunction and/or CAAs.
  • Analysis of demographic data, echocardiographic findings, laboratory results, and COVID-19 variants.

Main Results:

  • 38% of MIS-C patients had decreased left ventricular ejection fraction (LVEF), and 44% had CAAs.
  • Patients admitted to the pediatric intensive care unit (PICU) were older and had cardiac dysfunction.
  • Higher CRP and lower albumin levels were observed in older patients with cardiac dysfunction in the PICU.

Conclusions:

  • Cardiac dysfunction and CAAs are significant concerns in MIS-C patients.
  • Older age, elevated CRP, and low albumin are associated with cardiac involvement in MIS-C.
  • Early identification and monitoring of cardiac function are essential for managing MIS-C.
Abstract

Related Concept Videos

Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
21
Pericarditis II: Clinical Features and Diagnostic Tests01:19

Pericarditis II: Clinical Features and Diagnostic Tests

Pericarditis is distinguished by inflammation of the pericardium, the fibrous sac that encases the heart. It can be acute, lasting less than six weeks, or chronic, persisting for over three months. Understanding its clinical manifestations and diagnostic findings is crucial for timely and effective management.Clinical ManifestationsWhile pericarditis can be asymptomatic, it usually presents with characteristic symptoms such as:Chest Pain: The most characteristic symptom of pericarditis is chest...
24
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
25
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
58
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
16
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
30